ResMedvs.Stryker
RMD vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 4.0× larger than ResMed by market cap; ResMed trades at the lower P/E (21.5 vs 35.2); year to date, ResMed leads (−3.5% vs −6.7%).
Side by side
| RMD | SYK | |
|---|---|---|
| Market cap | $32.7B | $131B |
| Price | $236.59 | $330.59 |
| Today | +1.8% | +0.8% |
| Return YTD | −3.5% | −6.7% |
| Return 1Y | −20.9% | −16.8% |
| P/E | 21.5 | 35.2 |
| P/S | 5.8 | 5.1 |
| P/B | 5.0 | 5.5 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More RMD & SYK comparisons
Other head-to-heads in the Medtech & devices segment.
See where RMD and SYK sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →